The U.S. Department of Agriculture’s (USDA) Food Safety and Inspection Service (FSIS) and the U.S. Department of Health and Human Services’ (HHS) Food and Drug Administration (FDA) today announced a formal agreement to jointly oversee the production of human food products derived from the cells of livestock and poultry.
.jpg)
FDA is warning of the possibility of a shortage of sterilized medical devices, possibly posing a threat to public health.
Safety concerns have led to a government warning about a wearable defibrillator.
For two decades, CDER has used certain methods to speed drug development and the regulatory review process so that promising therapies can get to patients faster.
Drug shortages have a significant impact on both hospitals and patients.
An audio podcast series featuring the Director of FDA Center for Drug Evaluation and Research
The Forum will focus on the latest trends and enhancements in laser-based imaging modalities such as Optical Coherence Tomography (OCT) and Adaptive Optics (AO), regulatory and reimbursement considerations, and new topics of interest such as the Medical Device Development Tool Program and the emerging role of Artificial Intelligence.
On Tuesday, March 19, 2019, the FDA will host a webinar to share information and answer questions regarding the implementation of the final rule on “Human Subject Protection; Acceptance of Data From Clinical Investigations for Medical Devices.”
On Thursday, March 14, 2019, the FDA will host a webinar on the final guidance entitled, "The Least Burdensome Provisions: Concept and Principles."
Advances in technology and material science are enabling new opportunities to transform health and mobility through innovations in medical products.
At the FDA, protecting patient and consumer health is our highest priority.
The use of dietary supplements, such as vitamins, minerals or herbs, has become a routine part of the American lifestyle.
A key element of the U.S. Food and Drug Administration’s mission is focused on helping to ensure that all products we regulate, including drugs available to consumers, are safe and of high quality.